MedTrace Logo

Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis

NCT06598982 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of this study was to investigate respiratory muscle sarcopenia in individuals with systemic sclerosis. The main question it aims to answer is:

What is the prevalence of respiratory muscle sarcopenia in patients with systemic sclerosis? Participants body composition (bioelectrical impedance), hand grip strength (hand dynanometer), physical performance tests (5 repetition sit-and-stand test, 4-meter walk test, Timed up-and-go test) and respiratory muscle strength were evaluated.

Conditions

  • Systemic Sclerosis (SSc)
  • Scleroderma

Sponsors & Collaborators

  • Selcuk University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-01-02
Completion
2025-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06598982 on ClinicalTrials.gov